Prof. MD. Fikret Arpacı

Prof. MD.

Fikret Arpacı

Medical Oncology
Single Form Doctors

Areas of Interests

  • High Dose Chemotherapy
  • Bone Marrow (Stem Cell) Transplantation 
  • (Autologous, Allogeneic, Haploidentic) 
  • Lymphoma, Leukemia, Breast, Lung, Colon, Stomach and Other Cancers
27

h-index

Education

  • University of South Carolina, Department of Transplantation (1995-1996)
  • War Academy Dispensary (1985-1987)
  • GATA Faculty of Medicine (1984)
  • Istanbul University Faculty of Medicine (1978-1983)
Experience
  • Liv Hospital Ankara 2014
  • Medical Oncology
  • Bone Marrow Transplant
  • GATA Medical Oncology and Bone Marrow Transplant Center (1992-2014)
  • GATA Internal Medicine (1987-1991)
  • Sarıkamış Military Hospital (1992)
27

h-index

Education

  • University of South Carolina, Department of Transplantation (1995-1996)
  • War Academy Dispensary (1985-1987)
  • GATA Faculty of Medicine (1984)
  • Istanbul University Faculty of Medicine (1978-1983)
Experience
  • Liv Hospital Ankara 2014
  • Medical Oncology
  • Bone Marrow Transplant
  • GATA Medical Oncology and Bone Marrow Transplant Center (1992-2014)
  • GATA Internal Medicine (1987-1991)
  • Sarıkamış Military Hospital (1992)
  •  
  • International Article:91
    National Article 92
    International Article Refereeing: 11
    International Conference Presentation: 3
    International Congress Session Chair: 2
    International Paper – Poster: 131
    National Paper – Oral – Poster: 233
    Book (Turkish) Editor: 1
    Book Chapter (Turkish): 10
    Book (International) Chapter: 2International Article:91
    National Article 92
    International Article Refereeing: 11
    International Conference Presentation: 3
    International Congress Session Chair: 2
    International Paper – Poster: 131
    National Paper – Oral – Poster: 233
    Book (Turkish) Editor: 1
    Book Chapter (Turkish): 10
    Book (International) Chapter: 2International Article:91
    National Article 92
    International Article Refereeing: 11
    International Conference Presentation: 3
    International Congress Session Chair: 2
    International Paper – Poster: 131
    National Paper – Oral – Poster: 233
    Book (Turkish) Editor: 1
    Book Chapter (Turkish): 10
    Book (International) Chapter: 2International Article:91
    National Article 92
    International Article Refereeing: 11
    International Conference Presentation: 3
    International Congress Session Chair: 2
    International Paper – Poster: 131
    National Paper – Oral – Poster: 233
    Book (Turkish) Editor: 1
    Book Chapter (Turkish): 10
    Book (International) Chapter: 2
  • International Article:91
  • National Article 92
  • International Article Refereeing: 11
  • International Conference Presentation: 3
  • International Congress Session Chair: 2
  • International Paper – Poster: 131
  • National Paper – Oral – Poster: 233
  • Book (Turkish) Editor: 1
  • Book Chapter (Turkish): 10
  • Book (International) Chapter: 2
  • The relationship between disease features and quality of life in patients with cancer—I
  • V Isikhan, P Güner, S Kömürcü, A Özet, F Arpaci, B Öztürk
  • Cancer nursing 24 (6), 490-495
  • 197      2001
  • Patients’ preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of …
  • X Pivot, J Gligorov, V Müller, G Curigliano, A Knoop, S Verma, V Jenkins, …
  • Annals of oncology 25 (10), 1979-1987
  • 194      2014
  • Serum copper and zinc levels and copper/zinc ratio in patients with breast cancer
  • I Yücel, F Arpaci, A Özet, B Döner, T KarayilanoĞlu, A Sayar, Ö Berk
  • Biological trace element research 40, 31-38
  • 155      1994
  • Hematopoietic stem cell transplantation in patients with gain-of-function signal transducer and activator of transcription 1 mutations
  • JW Leiding, S Okada, D Hagin, M Abinun, A Shcherbina, DN Balashov, …
  • Journal of Allergy and Clinical Immunology 141 (2), 704-717. e5
  • 153      2018
  • Development of rational in vitro models for drug resistance in breast cancer and modulation of MDR by selected compounds
  • MD Kars, ÖD Işeri, U Gündüz, AU Ural, F Arpaci, J Molnár
  • Anticancer Research 26 (6B), 4559-4568
  • 149      2006
  • Drug resistant MCF-7 cells exhibit epithelial-mesenchymal transition gene expression pattern
  • ÖD Işeri, MD Kars, F Arpaci, C Atalay, I Pak, U Gündüz
  • Biomedicine & Pharmacotherapy 65 (1), 40-45
  • 141      2011
  • Effects of tamoxifen on the serum leptin level in patients with breast cancer
  • A Ozet, F Arpaci, MI Yilmaz, H Ayta, B Ozturk, S Komurcu, AA Yavuz, …
  • Japanese journal of clinical oncology 31 (9), 424-427
  • 120      2001
  • Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors
  • T Demirer, L Barkholt, D Blaise, P Pedrazzoli, M Aglietta, AM Carella, …
  • Nature clinical practice Oncology 5 (5), 256-267
  • 105      2008
  • Gene expression analysis of drug-resistant MCF-7 cells: implications for relation to extracellular matrix proteins
  • ÖD Işeri, MD Kars, F Arpaci, U Gündüz
  • Cancer chemotherapy and pharmacology 65, 447-455
  • 93        2010
  • Low serum leptin level in colon cancer patients without significant weight loss
  • F Arpaci, MI Yilmaz, A Ozet, H Ayta, B Ozturk, S Komurcu, M Ozata
  • Tumori Journal 88 (2), 147-149
  • 77        2002
  • Cumulative prior dose of cisplatin as a cause of the nephrotoxicity of highdose chemotherapy followed by autologous stemcell transplantation
  • K Caglar, C Kinalp, F Arpaci, M Turan, K Saglam, B Ozturk, ş Komurcu, …
  • Nephrology Dialysis Transplantation 17 (11), 1931-1935
  • 63        2002
  • Cerebellar aspergillosis: case report and literature review
  • E Erdogan, M Beyzadeoglu, F Arpaci, B Celasun
  • Neurosurgery 50 (4), 874-877
  • 62        2002
  • Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: a randomized study in patients …
  • S Ataergin, F Arpaci, M Turan, L Solchaga, T Cetin, M Ozturk, A Ozet, …
  • American journal of hematology 83 (8), 644-648
  • 58        2008
  • Identification of polymorphisms on the MDR1 gene among Turkish population and their effects on multidrug resistance in acute leukemia patients
  • P Kaya, U Gündüz, F Arpaci, AU Ural, S Guran
  • American journal of hematology 80 (1), 26-34
  • 58        2005
  • Total parenteral nutrition delays platelet engraftment in patients who undergo autologous hematopoietic stem cell transplantation
  • T Çetin, F Arpaci, Y Dere, M Turan, B Öztürk, ş Kömürcü, A Özet, …
  • Nutrition 18 (7-8), 599-603
  • 58        2002
  • The status of alternative treatment in cancer patients in Turkey
  • V Isikhan, S Komurcu, A Ozet, F Arpaci, B Ozturk, O Balbay, P Guner
  • Cancer Nursing 28 (5), 355-362
  • 54        2005
  • Quality of life and sociodemographic characteristics of patients with cancer in Turkey.
  • P Güner, V Isikhan, S Kömürcü, S Il, B Öztürk, F Arpaci, A Özet
  • Oncology nursing forum 33 (6)
  • 51        2006
  • Effect of dose-rate and lung dose in total body irradiation on interstitial pneumonitis after bone marrow transplantation
  • M Beyzadeoglu, K Oysul, B Dirican, F Arpaci, A Balkan, S Surenkok, …
  • The Tohoku journal of experimental medicine 202 (4), 255-263
  • 49        2004
  • Oxidative stress in patients undergoing high-dose chemotherapy plus peripheral blood stem cell transplantation
  • T Cetin, F Arpaci, MI Yilmaz, K Saglam, B Ozturk, S Komurcu, M Gunay, …
  • Biological trace element research 97, 237-247
  • 45        2004
  • Megestrol acetate for cachexia and anorexia in advanced non-small cell lung cancer: a randomized study comparing two different doses
  • HC Ulutin, F Arpaci, Y Pak
  • Tumori Journal 88 (4), 277-280
  • 44        2002
  • National survey of hemapheresis practice in Turkey (1998)
  • O Ilhan, N Üskent, Ö Arslan, M Arat, F Özkalemkaş, G Öztürk, …
  • Transfusion science 22 (3), 195-201
  • 37        2000
  • The feasibility of neoadjuvant highdose chemotherapy and autologous peripheral blood stem cell transplantation in patients with nonmetastatic high grade localized osteosarcoma …
  • F Arpaci, S Ataergin, A Ozet, K Erler, M Basbozkurt, A Ozcan, S Komurcu, …
  • Cancer: Interdisciplinary International Journal of the American Cancer …
  • 36        2005
  • GATA Tıbbi Onkoloji Bilim Dalı’nda izlenen hastaların bazı sosyodemografik özellikleri ve tanıları
  • S KILIÇ, ş KÖMÜRCÜ, M RZAYEV, A ÖZET, T KIR, F ARPACI, …
  • Gülhane Tıp Dergisi 46 (2), 115-124
  • 36        2004
  • Efficacy of melatonin, mercaptoethylguanidine and 1400W in doxorubicinand trastuzumabinduced cardiotoxicity
  • M Ozturk, M Ozler, YG Kurt, B Ozturk, B Uysal, N Ersoz, M Yasar, …
  • Journal of Pineal Research 50 (1), 89-96
  • 35        2011
  • Transient efficacy of double high-dose chemotherapy and autologous peripheral stem cell transplantation, immunoglobulin, thalidomide, and bortezomib in the treatment of …
  • S Ataergin, F Arpaci, M Demiriz, A Ozet
  • American journal of clinical dermatology 9, 271-273
  • 30        2008
  • Colon cancer during pregnancy. A case report.
  • S Kömürcü, B Oztürk, F Arpaci, MK Altundağ, Y Tezcan
  • The Journal of Reproductive Medicine 46 (1), 75-78
  • 30        2001
  • Paraneoplastic motor neuron disease resembling amyotrophic lateral sclerosis in a patient with renal cell carcinoma
  • HM Turk, A Ozet, O Kuzhan, F Komurcu, F Arpaci, B Ozturk, S Ataergin
  • Medical Principles and Practice 18 (1), 73-75
  • 28        2008
  • Detection of widespread neurolymphomatosis with 18F-FDG PET
  • E Öztürk, F Arpaci, M Kocaoğlu, N Arslan, N Bulakbaşi, M Özgüven
  • European Journal of Nuclear Medicine and Molecular Imaging 33, 975-976
  • 27        2006
  • Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for hepatic neuroendocrine metastases: initial experience at a single center
  • N Arslan, M Emi, E Alagöz, B Üstünsöz, K Oysul, F Arpacı, ş Uğurel, …
  • Vojnosanitetski pregled 68 (4), 341-348
  • 21        2011
  • Bilateral male breast cancer and prostate cancer: a case report
  • A Özet, AA Yavuz, S Kömürcü, B Öztürk, M Safali, F Arpaci, Z Çaliskaner
  • Japanese Journal of Clinical Oncology 30 (4), 188-190
  • 21        2000
  • Turkish Transplant Registry: a comparative analysis of national activity with the EBMT European Activity Survey
  • M Arat, F Arpaci, M Ertem, G Gürman
  • Bone marrow transplantation 42 (1), S142-S145
  • 17        2008
  • A successful and simplified filgrastim primed single apheresis method without large volume apheresis for peripheral blood stem cell collection
  • F Arpaci, S Kömürcü, B Öztürk, A Özet, C Kinalp, A Sengül, …
  • Japanese Journal of Clinical Oncology 30 (3), 153-158
  • 17        2000
  • Modified outpatient dexamethazone, cytarabine and cisplatin regimen may lead to high response rates and low toxicity in lymphoma
  • O Kanat, A Ozet, S Ataergın, F Arpacı, O Kuzhan, S Komurcu, B Ozturk, …
  • Medical Principles and Practice 19 (5), 344-347
  • 16        2010
  • Factors affecting engraftment time in autologous peripheral stem cell transplantation
  • HM Turk, S Komurcu, F Arpaci, A Ozet, S Kilic, O Kuzhan, B Ozturk, …
  • Asian Pac J Cancer Prev 11 (3), 697-702
  • 16        2010
  • Self-reported experience of mucositis in cancer patients who underwent conditioning regimen and stem cell transplantation
  • M Ozturk, S Komurcu, S Kilic, A Ozet, F Arpaci, B Ozturk, O Kuzhan, …
  • Supportive care in cancer 17, 1295-1299
  • 16        2009
  • West Nile virus infection in a patient with acute graft-versus-host disease
  • F Arpaci, T Cetin, A Kubar, M Ozturk, O Kuzhan, S Komurcu, B Ozturk, …
  • HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 94, 687-687
  • 16        2009
  • VAD combination chemotherapy followed by bortezomib may be an effective treatment in secondary plasma cell leukemia
  • S Ataergin, F Arpaci, A Kaya, T Kaya, O Gunhan
  • American journal of hematology 81 (12), 987-988
  • 16        2006
  • GCSFmobilized haploidentical peripheral blood stem cell transplantation in children with poor prognostic nonmalignant disorders
  • F Arpacı, I Tezcan, O Kuzhan, N Yalman, D Uçkan, AE Kürekçi, …
  • American journal of hematology 83 (2), 133-136
  • 13        2008
  • Donor cell leukemia in a patient developing 11 months after an allogeneic bone marrow transplantation for chronic myeloid leukemia
  • S Ataergin, F Arpaci, T Cetin, S Guran, C Yakicier, M Beyzadeoglu, A Ozet
  • American journal of hematology 81 (5), 370-373
  • 13        2006
  • Evaluation of fractionated total body irradiation and dose rate on cataractogenesis in bone marrow transplantation.
  • M Beyzadeoglu, B Dirican, K Oysul, F Arpaci, Y Pak
  • Haematologia 32 (1), 25-30
  • 13      &
  •  
  • Gülhane Medical Journal
  • Turkish Journal of Caner
  • Turkish Journal of Clinical Medical Sciences
  • Turkish Journal of Hematology
  • Turkish Journal of Hematology and Oncology
  • International Bone Marrow Transplant Center (IBMTR)
  • European Bone Marrow Transplant (EBMT)
  • European Society of Medical Oncology (ESMO)
  • Turkish Bone Marrow Registry (TTR)
  • Turkish Society of Medical Oncology (TTOD)
  • Turkish Hematology Association (THD)
  • Turkish Oncology Group (TOG)
  •